Paul Gray Parker - Dec 29, 2023 Form 4 Insider Report for CLOROX CO /DE/ (CLX)

Role
Director
Signature
By Cheryl Brice, Attorney-in-Fact for
Stock symbol
CLX
Transactions as of
Dec 29, 2023
Transactions value $
$13,118
Form type
4
Date filed
1/3/2024, 04:44 PM
Previous filing
Oct 3, 2023
Next filing
Apr 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
transaction CLX Common Stock +Grant/Award $13,118 +92 +14.72% $142.59 717 Dec 29, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLX Deferred Stock Units +Grant/Award $0 +19 +0.91% $0.00 2,086 Nov 9, 2023 Common Stock 19 Direct F2, F3, F4
transaction CLX Deferred Stock Units +Grant/Award $0 +1,117 +53.56% $0.00 3,203 Dec 29, 2023 Common Stock 1,117 Direct F2, F4, F5

Explanation of Responses:

Id Content
F1 Receipt of Common Stock in lieu of portion of quarterly director's fee.
F2 1-for-1
F3 Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.
F4 The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.
F5 Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan.